$807.417
+2.422 (+0.30%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de REGN por análisis de gráficos similares
Alphio's REGN stock price prediction model matches the current Regeneron Pharmaceuticals Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $808.79 (+0.17%). The 1-week path is $817.99 (+1.31%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de Regeneron Pharmaceuticals Inc?
Regeneron Pharmaceuticals Inc is a good buy right now, with a current price of $805.02 and a forward P/E ratio of 14.51, suggesting it is undervalued compared to its earnings potential. The stock has shown a 1-year change of +37.54%, reflecting strong growth, and analysts project further increases, with a target price of $908 from BofA. The main risk is the recent decline in stock price, down 1.72% yesterday, which could indicate short-term volatility.
REGN cerró en $807.42 el Monday, tras subir +0.30%
Regeneron Pharmaceuticals Inc (REGN) last closed at $807.4174805, gaining +0.30%. These facts feed the 1-day and 1-week REGN price prediction above.
Consenso de analistas
Regeneron Pharmaceuticals Inc (REGN): 13 comprar, 12 mantener, 1 vender. Perspectiva: Buy.
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
Factores de la previsión
Los factores de la previsión de Regeneron Pharmaceuticals Inc (REGN) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bullish
SMA 200
Bullish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de REGN, ordenadas por similitud.
Análisis de estacionalidad de REGN
Historically the probability of a positive October return for REGN is 48.44%. August offers the highest probability of a positive month at 60.94%, while November is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Proyecciones de precio a 10 años de REGN
| Mes | Precio mínimo | Precio medio | Precio máximo | ROI potencial |
|---|---|---|---|---|
| Oct 2026 | $532.77 | $606.87 | $618.10 | -24.84% |
| Nov 2026 | $582.01 | $654.23 | $691.74 | -18.97% |
| Dec 2026 | $606.44 | $711.92 | $785.14 | -11.83% |
En 2026, se proyecta que Regeneron Pharmaceuticals Inc (REGN) oscile entre $532.77 y $785.14.
Previsión mensual de Regeneron Pharmaceuticals Inc para 2026
En Oct de 2026, se proyecta que Regeneron Pharmaceuticals Inc promedie $606.87, con un mínimo de $532.77 y un máximo de $618.10.
En Nov de 2026, se proyecta que Regeneron Pharmaceuticals Inc promedie $654.23, con un mínimo de $582.01 y un máximo de $691.74.
En Dec de 2026, se proyecta que Regeneron Pharmaceuticals Inc promedie $711.92, con un mínimo de $606.44 y un máximo de $785.14.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.